- have
resistance to
multiple drugs simultaneously. Artemisinin-based
monotherapies for
malaria are
explicitly discouraged to
avoid the
problem of developing...
-
Lumateperone (Caplyta) –
approved as a
monotherapy for
bipolar depression Lurasidone (Latuda) –
approved as a
monotherapy for
bipolar depression Quetiapine...
-
treatment of
schizophrenia as well as
bipolar depression, as
either monotherapy or
adjunctive therapy (with
lithium or valproate). It is
developed by...
-
Multiple studies suggest hydrochlorothiazide could be used as
initial monotherapy in
people with
primary hypertension; however, the
decision should be...
- well-studied and characterized. The most
common side
effects of
bicalutamide monotherapy in men
include breast tenderness,
breast growth, feminization, demasculinization...
-
against placebo, or that it is more
effective than an
existing drug. In
monotherapy (where only one drug is taken) it is
considered unethical by most to...
- an
antacid monotherapy arm. A
robust double-blind
clinical trial performed in 2003 by
Berman et al.
compared 30 mL of
antacid monotherapy,
antacid with...
-
Weston J,
Tudur Smith C (August 2018). "Sodium
valproate versus phenytoin monotherapy for epilepsy: an
individual parti****nt data review". The
Cochrane Database...
-
inhibit anaerobic organism growth and reproduction.
Hyperbaric oxygen as a
monotherapy is
controversial in its lack of efficacy,
surgery and
antibiotic administrations...
- and Drug
Administration (FDA) to
treat bipolar depression,
either as
monotherapy or
adjunctively with
lithium or valproate. It has no
effect on manic...
